Lorlatinib and the Enigma of Autoantibody-Negative Diabetes
Patients on lorlatinib may develop diabetes with unusual characteristics, including the absence of typical autoantibodies. This presents a diagnostic challenge, requiring clinicians to consider drug-induced etiologies even when initial immunological markers are negative.
ECPR Rewarming: A Case for Prolonged Resuscitation?
Hypothermia can be protective, even in the face of cardiac arrest and severe coagulopathy. This case challenges the premature termination of resuscitation efforts in severely hypothermic patients undergoing extracorporeal cardiopulmonary resuscitation (ECPR).
Addiction Recovery: A Canadian Perspective on a Global Crisis
The Canadian Academy for Addiction Psychiatry (CAAP) highlights the urgent need for enhanced mental health and addiction treatment services, especially in the wake of the COVID-19 pandemic. Their commentary provides a framework that other countries might consider, although questions of scalability remain.
Metformin, Liraglutide, and Gut Microbiome Shifts in Youth-Onset T2D
Youth-onset type 2 diabetes (T2D) poses unique challenges, and this study sheds light on how common treatments like metformin and liraglutide impact the gut microbiome. Understanding these shifts may allow for more targeted therapies and improved outcomes in this vulnerable population.
What Still Eludes Us in MASH Research?
MASH (metabolic dysfunction-associated steatohepatitis) is a complex disease, and while we've made strides, key mechanistic details remain elusive. This demands a sharper focus on translational studies that can directly inform clinical practice.
